Stock Price, News, Quote and Profile of SILEXION THERAPEUTICS CORP(NASDAQ:SLXN) stock

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

SILEXION THERAPEUTICS CORP

NASDAQ:SLXN (11/20/2024, 8:00:02 PM)

Premarket: 0.272 -0.06 (-18.34%)

0.3331

+0.11 (+47.26%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorN/A

GICS IndustryN/A

GICS SubIndustry

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Chartmill High Growth Momentum

EPS Q2Q%

Sales Q2Q%

CRS

6 MonthN/A

Overview

Earnings (Last)

Earnings (Next)

Ins Owners

Inst Owners

Market Cap4.61M

PEN/A

Fwd PEN/A

Dividend YieldN/A

Analysts

IPO

Stock Screener Links

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Company Profile

Moringa Acquisition Corp. operates as a blank check company. The company is headquartered in New York City, New York and currently employs 0 full-time employees. The company went IPO on 2021-02-17. The firm is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company intends to focus its search on technology-based businesses that are domiciled in Israel, that carry out all or a substantial portion of their activities in Israel, or that have some other significant Israeli connection. The company has no operations and generates no revenues.